Skip to main content
Have a personal or library account? Click to login
Antibody-Mediated Rejection in Kidney Transplant Recipients Cover

References

  1. Anonymous. (2009).Department of health and human services, Rockville, MD.
  2. Anonymous. (2010).Osterlee, A., Ramel, A. Central Office. Leiden. The Netherlands.
  3. Archdeacon, P., Chan, M., Neuland, C., Velidedeoglu, E., Meyer, J., Tracy, L., Cavaille-Coll, M., Bala, S., Hemandez, A., Albrecht, R. (2011). Summary of FDA Antibody-Mediated Rejection Workshop..,, 896-906.
  4. Bartel, G., Wahrmann, M., Regel, H. (2010). Peritransplant immunoadsorption for positive crossmatch deceased donor kidney transplantation..,, 2033-2041.
  5. Billen, E., Christiaans, M., van denBerg-Loonen, E. (2009). Clinical relevance of Luminex donor-specific crossmatches: Data from 165 renal transplants.,(3), 205-211.
  6. Bruce, V., Suranyi, M. (1995). Understanding rejection. In:. Wood, K. (ed.) MedSci, Oxford, pp. 113-133.
  7. Burns, J., Cornell, L., Perry, D., Pollinger, H., Gloor, J. (2008). Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation..,, 2684-2694.
  8. Cecka, J. (2011). Current methodologies for detection sensitization to HLA antigens..,, 398-411.
  9. Chapmen, J., Taylor, C., Ting, A., Morris, P. (1986). Hypereacute rejection of renal allograft in the presence of anti-HLA Cw5 antibody.,, 91-95.
  10. Claas, F., Rahmel, A., Doxiadis, I. (2009). Enhanced kidney allocation to highly sentized patients by the acceptable mismatch program.,, 447-453
  11. Clatworthy, M. R. (2011). Targeting B cells and antibody in transplantation..,, 1359-1367.
  12. Collins, A., Scheeberger, E., Pascual, M. (1999). Compliment activation in acute humoral renal allograft rejection: Diagnostic significance of C4d deposits in peritubular capillaries..,, 2208-2215.
  13. Colvin, R. (2007). Antibody-mediated renal allograft rejection: Diagnosis and pathogenesis..,, 1046-1056.
  14. Danovitch, G. (ed.). (2010).. Philadelphia: Wolter Kluwer. 471 pp.
  15. Dragun, D., Muller, D., Brasen, M. (2005). Angiotensin II Type I-receptor activating antibodies in renal allograft rejection.., 352, 558-569.
  16. Einecke, G., Sis, B., Reeve, J., Mengel, M., Husain, S. (2009). Antibody- mediated microcirculation injury is the major cause of late kidney transplant failure..,, 2520-2509.
  17. Everly, M., Terasaki, P., Trivedt, H. (2012). Durability of antibody removal following proteasome inhibitor-based therapy.,, 572-577.
  18. Fehr, T., Gaspert, A. (2012). Antibody-mediated kidney allograft rejection: Therapeutic options and their experimental rationale.., 25, 623-632.
  19. Feucht, H, Schneeberger, H, Hillebrand, G. (1993). Capillary deposition of C4d complement fragment and early renal graft loss.43, 1333-1341.
  20. Fuggle, S., Martin, S. (2008). Tools for human leukocyte antigen antibody detection and their application to transplanting sensitized patients.,, 384-389.
  21. Gaston, R., Cecka, J., Kasiske, B. (2010). Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation, 90, 68-76
  22. Gebel, H., Bray, R. (2000). Sensitization and sensitivity: Defining the unsensitized patient.,, 1370-1374.
  23. Gloor, J., Sethi, S., Stegall, M., Cosio, F., Rea, D. (2007). Transplant glomerulopathy: Subclinical incidence and association with alloantibody..,, 2124-2130.
  24. Halloran, P., de Freitas, D., Einecke, G., Solez, K., Ritchie, A. (2010). An integrated view of molecular changes, histopathology and outcomes in kidney transplant.,, 2223-2230.
  25. Halloran, P., Wadgymar, A., Ritchie, S., Falk, J., Solez, K., Srinivasa, N. (1990). The significance of anti-class I antibody response. I. Clinical and pathologic features of anti-class I- mediated rejection,, 85-89.
  26. Hricik, D. (ed.). (2011).Willey-Blackwell, UK. 307 pp.
  27. Kamar, N., Milioto, O., Puissant-Librano, B., Esposito, L., Pierre, M. C., Mohamed, A. O., Lavayssière, L., Cointault, O., Ribes, D., Cardeau, I., Nogier, M. B., Durand, D., Abbal, M., Blancher, A., Rostaing, L. (2010). Incidence and predictive factors for infections disease after rituximab therapy in kidney-transplant patients..,, 89-98.
  28. Lefaucheur, C., Suberbielle-Boissel, C., Hill, G. (2009). Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation..,, 1-11.
  29. Lefaucheur, C., Loupy, A., Hill, G. (2010). Preexisiting donor-specific HLA antibodies predict outcome in kidney transplantation. J..,, 1398-1407.
  30. Lefaucheur, C., Antonie, C., Suberbielle, C., Glotz, D. (2011). Mastering the risk of HLA antibodies in kidney transplantation: An algorithm based on pretransplant single-antigen flow bead techniques..,, 1592-1598.
  31. Loupy, A., Suberbielle-Boissel, C., Hill, G., Nochy, D. (2009). Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies., 2561-2570.
  32. Loupy, A., Hill, G., Suberbielle, C. (2011). Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with performed donor-specific antibodies (DSA)., 56-67.
  33. Mao, Q., Terasaki, P., Cai, J. (2007). Extremely high association between appearance of HLA antobodies and failure of kidney graft in a five-year longitudinal study., 864-875.
  34. Marrari, M., Duquesnoy, R. (2010). Detection of donor-specific HLA antibodies before and after removal of a rejected kidney transplant..,, 105-111.
  35. McDonald, S., Russ, G., Campbell, S., Chadban, S. (2007). Kidney transplant rejection in Australia and New Zealand: Relationships between rejection and graft outcome.7, 1201-1208.
  36. Mengel, M., Sis, B., Haas, M., Colvin, R., Halloran, P., Racusen, L. (2012). Banff 2011 meeting report: New concepts in antibody-mediated rejection., 563-570.
  37. Mengel, M., Husain, S., Hidalgo, L., Sis, B. (2012). Phenotypes of antibody- mediated rejection in organ transplant..,, 611-622.
  38. Montgomery, R. (2010). Renal transplantation across HLA and ABO antibody barriers: Integrating paired donation into desensitization protocols., 449-458.
  39. Morath, C., Opelz, G., Zeier, M., Susal, C. (2012). Prevention of antibody- mediated kidney transplant rejection..,, 633-645.
  40. Muthukumar, T., Mueller, F., Anglicheau, D., Sharma, V., Ding, R., Suthanthiran, M. (2011). Intragraft microRNA expression signatures of interstitial fibrosis and tubular athrophy of human renal allograft., 291-298.
  41. Navkivel, B., Alexander, S. (2010). Mechanisms of disease: Rejection of kidney allograft., 1451-1461.
  42. Poduval, R., Kadambi, P., Josephson, M., Cohn, R., Harald, R. (2005). Implications of immunohistochemical detection of C4d along peritubular capillaries in late acute renal allograft rejection.,, 228-235.
  43. Roelen, D., Doxiadis, I., Claas, F. (2012). Detection and clinical relevance of donor specific HLA antibodies: A matter of debate.,, 604-610.
  44. Schnaidt, M., Weinstock, C., Jurisic, M., Schmidt-Horch, B., Ender, A, Wernet, D. (2011). HLA antibody specification using single-antigen beads-a technical solution for the prozone effect.,, 510-515.
  45. Sellares, J., de Frietas, D., Mengel, M., Reeve, J., Matas, A., Halloran, P. (2012). Understanding the causes of kidney transplant failure: The dominant role of antibody-mediated rejection and nonadherence., 388-399.
  46. Shehata, N., Palda, V., Meyer, R. (2010). The use of immunoglobulin therapy for patients undergoing solid organ transplantation: An evidence-based practice guideline..,(suppl.1) S7.
  47. Sis, B., Jhangri, G., Riopel, J., Chang, D., de Freitas, D. G., Hidalgo, L., Mengel, M., Matas, A., Halloran, P. F. (2012). A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplant., 1168-1179.
  48. Stegall, M., Gloor, J., Winters, J., Moore, S., Degoey, S. (2006). A comparison of plasmapheresis versus high dose IVIG desensitization in renal allograft recipients with high levels of donor-specific alloantibody., 346-353.
  49. Stegall, M., Dean, P., Gloor, J. (2009). Mechanisms of alloantibody production to sensitized renal allograft recipients., 998-1006.
  50. Susal, C., Dohler, B., Opelz, G. (2009). Presensitized kidney graft recipient with HLA class I and II antibodies are at increased risk for graft failure: A collaborative transplant study report..,, 59-67.
  51. Terasaki, P. (2003). Humoral theory of transplantation..,, 665-673.
  52. Tripkov, K., Cambell, P., Pazderka, F., Cocfield, S., Solez, K., Halloran, P. (1996). Pathologic features of acute renal allograft rejection associated with donor-specific antibody.,, 1586-1591.
  53. Vaidya, S., Partlow, D., Susskind, B., Noor, M., Barnes, T., Gugliuzza, K. (2006). Prediction of cross-match outcome in highly sensitized patients by single and/or multiple antigen bead luminex assay.,, 1524-1532.
  54. Venetz, J., Pascual, M. (2007). New treatments for acute humoral rejection in kidney allograft..,, 625-632.
  55. Wiebe, C., Gibson, I., Blydt-Hansen, T., Karpinski, M., Ho, J. (2012). Evolution and clinical pathologic correlation of de novo donor-specific HLA antibody post kidney transplant., 1157-1167.
  56. Zachary, A., Montgomery, R., Ratner, L., Racusen, L. (2003). Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients.,, 1519-1525.
  57. Zachary, A., Lucas, D., Detrick, B., Leffel, M. (2009). Naturally occurring interference in Luminex assay for HLA-specific antibodies: Characteristics and resolution..,, 496-502.
  58. Zeevi, A., Girnita, A., Duquesnoy, R. (2006). HLA antibody analysis: Sensitivity, specificity, and clinical significance in solid organ transplantation..,, 255-264.
  59. Zou, Y., Stasny, P., Susal, C., Dohler, B., Opelz, G. (2007). Antibodies against MICA antigens and kidney transplant rejection., 1293-3000.
DOI: https://doi.org/10.2478/prolas-2013-0001 | Journal eISSN: 2255-890X (formerly 1407-009X) | Journal ISSN: 1407-009X
Language: English
Page range: 2 - 8
Published on: Jun 8, 2013
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services

© 2013 Rafails Rozentâls, Ieva Ziediņa, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons License.